Skip to main content

ADVENT Post Approval Study

Active, not recruiting · NCT06431815

Conditions: Paroxysmal Atrial Fibrillation

At a glance

Research payments reported, 2025
$838,222
U.S. investigators named
24
Sites paid
24
Planned or actual enrollment
228

About the trial

Sponsor
Boston Scientific Corporation
Tested
FARAPULSE™ Pulsed Field Ablation System (device)
Dates
Started 2024-09-25; completion 2029-10
Results posted
Not yet

The ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.

From ClinicalTrials.gov, last updated 2026-10-23. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Boston Scientific Corporation reported $838,222 in research payments for this study in 2025 (86 payments).

Products named: Clinical Trial Product

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.